We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cardiome -- CRME
An SI Board Since July 2006
Posts SubjectMarks Bans Symbol
285 19 0 CRME
Emcee:  tuck Type:  Unmoderated
Min  Hr  Day  Wk  Mon  Yr  3 Yr  Log
CRME 2.330-2.1%May 16 4:00 PM EDT
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
285Sounds like oral Kynapid development will proceed... ++++++++++++++++ CardiomeIan@SI-12/29/2010
284P3b of IV vernakalant halted due to serious AE in South America. >>VANCOUtuck-10/21/2010
283Fairly active in AH trading <pre> Sep. 1, 2010 Market Close: $ 6.19 AfterIan@SI-9/1/2010
282EDIT: TORONTO, Sept. 1 /CNW/ - Trading resumes in: << Issuer NamIan@SI-9/1/2010
281BUY OR SELL-Cardiome drug delay: mild stroke or intensive care? Thomson ReutersIan@SI-8/20/2010
280The market may fear this, but I don't think so. Merck did the deal just ovetuck-8/12/2010
279I suspect that until MRK/CRME announce otherwise the market will fear that MRK mIan@SI-8/11/2010
278The expectation was that the next phase of clinical development for oral vernakatuck-8/11/2010
277Another step toward Approval for IV Vernakalant: 7:30AM Merck: Investigational Ian@SI-6/25/2010
276BNN just interviewed Bob Rieder(Right name???), CRME's CEO. Good interview.Ian@SI-4/9/2009
275Merck & Co., Inc. and Cardiome Sign License Agreement for Vernakalant, an InIan@SI-4/8/2009
274Insider selling: Another margin call TORONTO (DOW JONES)--Cardiome Pharma CorpIan@SI-4/2/2009
273no messagekeokalani'nui-12/18/2008
272Amazes me that ceo's and crme is far from the first make their typical $1M irkrw-11/28/2008
271EDIT: TSE:COM actually closed at $5.44CDN. SI quote is a lower number for someIan@SI-11/28/2008
270<i>Doesn't mean there isn't need for better drug to send AF patienkeokalani'nui-11/11/2008
269>>Cardiome Provides Regulatory Update Thursday October 9, 12:20 pm ET VANtuck-10/9/2008
268Geez, don't give them any more ideas just in case your speculation isn'Ian@SI-8/11/2008
267I believe the "subset" refers to the severe congestive heart failure (idos-8/11/2008
266>Prior to considering approval, FDA requires additional information associateformer_pgs-8/11/2008
265>>Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAtuck-8/11/2008
264Unsure what's driving this: Potential buyers playing hardball?, or, a perk Ian@SI-7/23/2008
263Kenm RBC seems to share your view... 10:05 am Cardiome Pharma: . Target $13.5.Ian@SI-7/16/2008
262I believe you are correct. But it takes two to tango. So whomever decides to mkenhott-7/16/2008
261Haven't they put themselves on auction looking for a sale prior to an Oral VIan@SI-7/15/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):